# W3A #48 Acceptance Audit — Executable End-to-End Scenario

**Date:** 2026-09-24
**Result:** PASS / CLOSED
**Validated CI run:** 35989736313
**Validated commit:** 9a799e46fa914bd4f84d1d1039c9e783a5fce1d7

## Executed scope
A single bounded Pharma scenario now spans:
DS-003 constructed conditions → Risk Scenario → explicit synthetic Trigger/Event/Consequence → pre-treatment Assessment/Result → DS-003-derived proposed Treatment Strategy → synthetic Plan/Activity/Control → post-treatment reassessment/residual Result → Risk State history → independent Risk Register Workflow State history → responsibility-derived Risk Owner → CM-PharmE v1.0.0 external bridge.

## Predeclaration
Ten expected-answer families were frozen before executable implementation in:
`case/pharma/e2e-scenario-expected-v1.0.csv`.

## Runtime results
PostgreSQL:
- realized events: 1
- inherent/residual temporal results: 2
- derived owners: 1
- marker: `SEM_RISK_ISSUE_48_E2E_SCENARIO_PASS`

RDF:
- parsed graph: 592 triples
- predeclared structural answer families represented: 10/10
- marker: `SEM_RISK_ISSUE_48_RDF_SCENARIO_PASS`

## Semantic safeguards
- Scenario ≠ Event.
- Scenario Description ≠ Scenario/Event.
- Assessment Activity ≠ Assessment Result.
- Inherent/Residual results concern one underlying Risk identity.
- Strategy ≠ Plan ≠ Activity ≠ Control.
- Risk Owner is responsibility-derived; no primitive Risk.owner_id exists.
- Risk State ≠ Workflow State and histories are separately transitioned.
- CM-PharmE targets retain external ownership.
- DS-003 source-grounded content and synthetic execution elements remain explicitly distinguished.

## Claim boundary
PASS is executable application/verification evidence only. Synthetic trigger/event/control/reassessment data are not empirical evidence of causal strength, treatment effectiveness, prevalence, prediction or Pharma-wide generalizability.
